Logotype for FLUENT Corp

FLUENT (TIUM.U) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for FLUENT Corp

Q4 2024 earnings summary

25 Nov, 2025

Executive summary

  • Achieved record annual revenue of $103.6 million in 2024, a 6.4% increase year-over-year, driven by expansion and new brand launches.

  • Completed the acquisition of RIV Capital, expanding operational presence and adding retail, wholesale, and cultivation operations in New York.

  • Ended the year with over $40 million in cash and cash equivalents, supporting future growth initiatives.

  • Operations span Florida, New York, Pennsylvania, and Texas, with a diversified footprint and recent expansion.

  • Integration of new assets and operational improvements in cultivation yielded strong early results.

Financial highlights

  • Q4 2024 revenue was $24.9 million, down from $25.5 million in Q4 2023 due to price pressures in Florida.

  • Full-year adjusted EBITDA was $25 million, down from $27.2 million in 2023; Q4 adjusted EBITDA was $3 million, down from $6.9 million.

  • Cash flow from operations in Q4 was $14.7 million, up from $1.4 million in the prior year.

  • Reported a non-cash impairment of intangible assets of $64.3 million in Q4, related to the Florida cannabis license.

  • Net loss for 2024 was $40.4 million, compared to a net loss of $22.8 million in 2023.

Outlook and guidance

  • Plans to open three more stores in Florida by year-end, expanding to 45 locations across four states.

  • Two new cultivation facilities in Florida and New York expected online in 2025, targeting high-quality flower output.

  • Continued brand expansion in New York and Florida, with new product launches planned for 2025.

  • Positioned for growth in limited license markets with near- to medium-term adult-use transitions expected in NY, FL, and PA.

  • Texas market offers long-term potential as medical program expands.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more